Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

EBITDA Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual EBITDA in 2023 was -224 Million USD , up 6.66% from previous year.
Elanco Animal Health Incorporated's latest quarterly EBITDA in 2024 Q2 was 277 Million USD , down -34.78% from previous quarter.
Elanco Animal Health Incorporated reported an annual EBITDA of 866 Million USD in 2022, up 3.87% from previous year.
Elanco Animal Health Incorporated reported an annual EBITDA of 409 Million USD in 2021, up 84.87% from previous year.
Elanco Animal Health Incorporated reported a quarterly EBITDA of 277 Million USD for 2024 Q2, down -34.78% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly EBITDA of 166 Million USD for 2023 Q2, down -52.02% from previous quarter.

Annual EBITDA Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual EBITDA of Elanco Animal Health Incorporated (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-224 Million USD	6.66%
2022	866 Million USD	3.87%
2021	409 Million USD	84.87%
2020	-76.8 Million USD	-15.03%
2019	471.6 Million USD	-15.16%
2018	439.7 Million USD	-23.44%
2017	85.8 Million USD	54.68%
2016	232 Million USD	6.88%
2015	242.3 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	290 Million USD	169.37%
2024 Q2	277 Million USD	-34.78%
2023 Q2	166 Million USD	-52.02%
2023 Q4	147 Million USD	-15.03%
2023 FY	- USD	6.66%
2023 Q3	173 Million USD	4.22%
2023 Q1	346 Million USD	154.41%
2022 Q4	136 Million USD	-35.55%
2022 FY	- USD	3.87%
2022 Q3	211 Million USD	-21.27%
2022 Q2	268 Million USD	-22.32%
2022 Q1	345 Million USD	88.52%
2021 Q3	182 Million USD	-37.88%
2021 FY	- USD	84.87%
2021 Q4	183 Million USD	0.55%
2021 Q1	291 Million USD	297.0%
2021 Q2	293 Million USD	0.69%
2020 Q3	233.6 Million USD	57.84%
2020 Q4	73.3 Million USD	-68.62%
2020 FY	- USD	-15.03%
2020 Q1	105 Million USD	-10.56%
2020 Q2	148 Million USD	40.95%
2019 Q4	117.4 Million USD	-12.45%
2019 Q3	134.1 Million USD	-11.78%
2019 Q2	152 Million USD	8.96%
2019 FY	- USD	-15.16%
2019 Q1	139.5 Million USD	-25.24%
2018 Q4	186.6 Million USD	12.55%
2018 FY	- USD	-23.44%
2018 Q3	165.8 Million USD	60.5%
2018 Q2	103.3 Million USD	-33.01%
2018 Q1	154.2 Million USD	-49.14%
2017 Q1	140.9 Million USD	0.0%
2017 Q4	303.2 Million USD	171.68%
2017 Q2	140.9 Million USD	0.0%
2017 Q3	111.6 Million USD	-20.79%
2017 FY	- USD	54.68%
2016 FY	- USD	6.88%
2015 FY	- USD	0.0%

Peer EBITDA Comparison of Elanco Animal Health Incorporated

Name	EBITDA	EBITDA Difference
Amneal Pharmaceuticals, Inc.	500.78 Million USD	144.73%
Bausch Health Companies Inc.	2.88 Billion USD	107.764%
Catalent, Inc.	-284 Million USD	21.127%
Emergent BioSolutions Inc.	-505.29 Million USD	55.67%
Perrigo Company plc	646.2 Million USD	134.664%
Teva Pharmaceutical Industries Limited	4.33 Billion USD	105.17%
Zoetis Inc.	3.68 Billion USD	106.079%